Exposing Cells to the Conditions of Ischemia-Reperfusion While Oxygenation is Monitored by the CLARIOstar with ACU

Life-threatening diseases such as myocardial infarction, stroke, or renal failure can occur due to interrupted oxygen flow. Cells and tissues are temporarily deprived of O2 (ischemia) and develop survival-strategies.

Additionally, upon re-oxygenation (reperfusion), cells are exposed to an additional threat by sudden oxygen increase. Despite being critical for survival, sudden reperfusion of tissue creates an inflammatory response and oxidative stress..

A trial set-up which mimics rapid fluctuations in O2 level is needed for assessment of biological effects of ischemia-reperfusion.

A microplate reader with software-regulated CO2 and O2 flow is employed in the ischemia-reperfusion model shown here. Fluctuations in oxygenation of Cor.4U® cardiomyocytes and HepG2 cells were recorded using an intracellular oxygen-sensitive fluorescent probe .

Read the full article including the methods, results and discussion.

The CLARIOstar® with ACU exposes cells to ischemiareperfusion conditions and monitors their oxygenation

About BMG Labtech

BMG LABTECH has been committed to producing microplate readers for more than twenty years. By focusing on the needs of the scientific community, the company’s innovative microplate readers have earned the company the reputation of being a technology leader in the field.

BMG LABTECH has developed a wide range of dedicated and multi-mode microplate readers for life sciences applications and high-throughput screening.

All BMG LABTECH microplate readers are "Made in Germany" and are conceived, developed, assembled, and tested entirely at our headquarters in Germany.

Since our establishment in Offenburg, Germany in 1989, BMG LABTECH has expanded to offer a worldwide sales and support network with offices in the USA, UK, Australia, Japan and France. Our subsidiaries, regional offices and distributors are committed to bringing you innovative microplate reader technology with the quality and reliability you expect from a German company.

Our staff includes engineers and scientists from the fields of biology, biochemistry, analytical chemistry, and physics.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Feb 1, 2020 at 3:07 PM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BMG LABTECH GmbH. (2020, February 01). Exposing Cells to the Conditions of Ischemia-Reperfusion While Oxygenation is Monitored by the CLARIOstar with ACU. News-Medical. Retrieved on June 17, 2024 from https://www.news-medical.net/whitepaper/20180730/Exposing-Cells-to-the-Conditions-of-Ischemia-Reperfusion-While-Oxygenation-Is-Monitored-by-the-CLARIOstar-with-ACU.aspx.

  • MLA

    BMG LABTECH GmbH. "Exposing Cells to the Conditions of Ischemia-Reperfusion While Oxygenation is Monitored by the CLARIOstar with ACU". News-Medical. 17 June 2024. <https://www.news-medical.net/whitepaper/20180730/Exposing-Cells-to-the-Conditions-of-Ischemia-Reperfusion-While-Oxygenation-Is-Monitored-by-the-CLARIOstar-with-ACU.aspx>.

  • Chicago

    BMG LABTECH GmbH. "Exposing Cells to the Conditions of Ischemia-Reperfusion While Oxygenation is Monitored by the CLARIOstar with ACU". News-Medical. https://www.news-medical.net/whitepaper/20180730/Exposing-Cells-to-the-Conditions-of-Ischemia-Reperfusion-While-Oxygenation-Is-Monitored-by-the-CLARIOstar-with-ACU.aspx. (accessed June 17, 2024).

  • Harvard

    BMG LABTECH GmbH. 2020. Exposing Cells to the Conditions of Ischemia-Reperfusion While Oxygenation is Monitored by the CLARIOstar with ACU. News-Medical, viewed 17 June 2024, https://www.news-medical.net/whitepaper/20180730/Exposing-Cells-to-the-Conditions-of-Ischemia-Reperfusion-While-Oxygenation-Is-Monitored-by-the-CLARIOstar-with-ACU.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.